InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Campbell Shannon. Director active across 2 companies, notably Black Diamond Therapeutics, Inc.. Aggregated, 4 reports have been logged. History available since 21 June 2024. The latest transaction was disclosed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations